Atlas Trials

Multi-Tracer PET Prediction and Assessment of Response to Gemcitabine in Pancreatic Cancer Patients

Clinical trial NCT02245217 · COMPLETED

Trial details

NCT number
NCT02245217
Sponsor
University of Utah
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2014-12-12
Primary completion
2016-03-17
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.